Assessment criteria
fecal occult blood, Bleeding, GUSTO, coronary occlusion, neurological deficits, neurological deficit symptoms
BLEEDING, EVENTS, CORONARY OCCLUSION, ISCHEMIC STROKE
We assessed focal neurological deficits by assessing the bNIHSS, which ranges from 0 to 43, with higher scores indicating worse deficits [Recurrent ischemic stroke—the aggravation of existing clinical symptoms or the emergence of new focal neurological deficit symptoms within 90 days after the first treatment—was confirmed by CT and MRI scans of the head, which showed obviously enlarged original lesions or new ischemic lesions. Bleeding events included intracranial and gastrointestinal mucosal hemorrhage, which were confirmed by head CT and gastric contents analysis or fecal occult blood test, respectively, within 90 days after treatment. According to the global use of streptokinase and tissue plasminogen activator to treat coronary occlusion (GUSTO) [